투자판단관련주요경영사항(임상시험계획승인신청등결정) (W2505 경구제 제 3상 임상시험계획(IND) 승인)[코]
Received: 8/21/2026 · Reporter: 지엘팜텍
지엘팜텍은 2026년 8월 21일 W2505 경구제의 제3상 임상시험계획(IND) 승인을 받았습니다.
🏢 Past 12 months filing pattern (this company)
- Total filings
- 22 filings
- Same category
- 9 filings
- Previous same-category filing
- 8/10/2026(11 days ago)
- Corrections / withdrawals
- 1 filing
Filing source / License
The original PDF/HTML of this filing is provided by FSS DART. MarketBubbles displays only metadata (title, receipt number, type, reporter) and a rule-based summary; we do not mirror the original PDF body (per FSS ToS).